FDA Inspection 1112378 — Nantong Jinghua Pharmaceutical Co., Ltd.

Nantong Jinghua Pharmaceutical Co., Ltd. — FEI 3003735909

The FDA completed an inspection of Nantong Jinghua Pharmaceutical Co., Ltd. on November 15, 2019 in Nantong. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Veterinary.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
November 15, 2019
Fiscal Year
2020
Product Type
Veterinary
Project Area
Monitoring of Marketed Animal Drugs, Feed, and Devices
Location
Nantong (China)